Skip to content. | Skip to navigation

Sections
IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.

 

Collaborators

The APGI is based at the Garvan Institute of Medical Research in Sydney and the Institute of Molecular Bioscience in Brisbane. Our collaborators include pancreatic cancer healthcare professionals and experts in major hospitals and research facilities across Australia. We also have international links with major pancreatic healthcare research centres in the USA, Canada and Italy. This project would not be possible without the dedication and support of each and everyone mentioned here. From the APGI team, a very big thank you to all!

New South Wales

Please click on the hospital of interest to view the collaborator's contact details.

Read More…

Queensland

Please click on the hospital of interest to view the collaborator's contact details.

Read More…

South Australia

Please click on the hospital of interest to view the collaborator's contact details.

Read More…

Victoria

Please click on the hospital of interest to view the collaborator's contact details.

Read More…

Western Australia

Please click on the hospital of interest to view the collaborator's contact details.

Read More…

International Partners

The APGI has established international links to global pancreatic cancer research groups to further our research endeavours.

Read More…